|
|
|
|
Дата |
|---|
| 30.09.2026 |
| 29.09.2026 |
| 28.09.2026 |
| 24.09.2026 |
| 23.09.2026 |
| 22.09.2026 |
| 21.09.2026 |
| 18.09.2026 |
| 17.09.2026 |
| 16.09.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
44.70
|
44.24
|
49.30
|
49.30
|
|
|
2 647 331 801.00
|
|
|
|
|
45.05
|
44.52
|
47.30
|
44.82
|
|
|
1 449 004 229.00
|
|
|
|
|
46.39
|
45.02
|
46.98
|
45.44
|
|
|
1 259 882 306.00
|
|
|
|
|
48.95
|
46.34
|
49.72
|
46.39
|
|
|
2 002 386 773.00
|
|
|
|
|
46.15
|
46.00
|
49.50
|
47.77
|
|
|
2 397 503 909.00
|
|
|
|
|
46.08
|
45.74
|
47.38
|
46.12
|
|
|
1 652 010 362.00
|
|
|
|
|
46.38
|
45.87
|
47.40
|
46.74
|
|
|
1 985 505 289.00
|
|
|
|
|
44.64
|
44.25
|
47.99
|
45.76
|
|
|
2 193 739 347.00
|
|
|
|
|
43.60
|
43.51
|
44.96
|
44.12
|
|
|
1 279 837 375.00
|
|
|
|
|
42.50
|
41.91
|
44.18
|
43.83
|
|
|
1 120 825 884.00
|
|
Период |
|---|
| 2025, регулярные |
| 2024, регулярные |
| 2023, регулярные |
| 2022, регулярные |
| 2021, регулярные |
| 2020, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2017, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
30.06.2026
|
29.06.2026 |
0.12 CNY |
|
14.08.2025
|
13.08.2025 |
0.03 CNY |
|
31.07.2024
|
30.07.2024 |
0.16 CNY |
|
25.07.2023
|
24.07.2023 |
0.4 CNY |
|
08.08.2022
|
05.08.2022 |
0.36 CNY |
|
05.08.2021
|
04.08.2021 |
0.35 CNY |
|
08.06.2020
|
05.06.2020 |
0.34 CNY |
|
10.04.2019
|
09.04.2019 |
0.3 CNY |
|
31.05.2018
|
30.05.2018 |
0.3 CNY |
Joinn Laboratories (China) Co Ltd is a China-based company principally engaged in the provision of pharmaceutical research and development outsourcing services. The Company operates its business through two segments. The Pharmaceutical Research and Development Outsourcing Services segment mainly provides non-clinical safety evaluation services, pharmacodynamic research services, animal pharmacokinetic research services and drug screening services. The Laboratory Animal Production and Marketing segment is principally engaged in the production and sales of laboratory animals such as mice, rats and monkeys as well as their ancillary products.
